Uli Hacksell

Biography

Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies; Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015) and led ACADIA from a private start-up to becoming a public multibillion dollar company. Previously, he held senior executive positions at Astra AB (1991–1999) and was president of Astra Draco, one of Astra’s largest R&D subsidiaries.  Uli has a diverse Board experience from several long-term assignments, including SynAct Pharma A/S, SLS Invest AB, Action Pharma A/S and the Swedish Medical Products Agency. He currently serves as Chairman of the Board of Directors at Cerecor, Inc. and is a Member of the Board of Directors at InDex Pharmaceuticals AB and Uppsala University. Earlier in his career he held the position of Professor in Organic Chemistry at Uppsala University where he also received his Ph.D. in 1981.

Research Interest

strategic planning, business development, pharmaceutical R&D and quality assurance